Clinical Trials
3 trialsNCT06111625 2023-11-01
Short-term Blinatumomab as a Bridge Therapy for Allo-HSCT in Low Burden B-ALL
Sichuan University
Phase 2 Recruiting
NCT06075212 2023-10-10
Immune Reconstitution After Allo-HSCT and Blinatumomab
Sichuan University
Unknown
NCT06075238 2023-10-10
Blinatumomab Prevents Recurrence of R/R ALL After Allo-HSCT
Sichuan University
Phase 2 Not yet recruiting